GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $294,000 | +0.7% | 6,744 | +0.5% | 0.04% | +15.4% |
Q1 2022 | $292,000 | -0.7% | 6,712 | +0.7% | 0.04% | 0.0% |
Q4 2021 | $294,000 | +17.6% | 6,667 | +4.3% | 0.04% | +14.7% |
Q3 2021 | $250,000 | -1.2% | 6,390 | +0.7% | 0.03% | -2.9% |
Q2 2021 | $253,000 | -1.9% | 6,348 | -12.1% | 0.04% | -7.9% |
Q1 2021 | $258,000 | -8.5% | 7,221 | -5.7% | 0.04% | -22.4% |
Q4 2020 | $282,000 | – | 7,661 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |